Don’t Rely Too Much on Those ‘GLP-1 Friendly’ Labels
Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in US supermarkets as a growing number of Americans try obesity drugs like Wegovy, Ozempic, Zepbound, and Mounjaro to lose weight. But the labels aren’t regulated by the FDA, unlike the popular medications themselves, so dieticians…
The protein boom: Starbucks, Subway and beyond load up menus
A growing list of restaurants are packing their menus with protein as more Americans opt for healthier diets. Subway recently announced that it was kicking off the year with new Protein Pockets. The Protein Pockets are described as soft tortillas with a selection of protein, such as chicken, ham and turkey, vegetables and a sauce. The company said that […]
Oprah has endured as a weight-loss icon. Not even GLP-1s can change that.
Oprah Winfrey has massively influenced wellness and diet culture for decades, now taking the spotlight to share her experience with GLP-1s. Don Arnold/Getty Images Oprah Winfrey has long been an influential figure in the health and wellness industry. Her recent comments about GLP-1s mark a turning point in how we think about losing weight. Experts […]
Novo’s Wegovy Pill Looks A Lot Like Zepbound — In One Week – Investor’s Business Daily
Novo’s Wegovy Pill Looks A Lot Like Zepbound — In One Week Investor’s Business Daily Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch CNBC Lubbock Doctor compares weight loss injections to new pills KCBD Novo Nordisk Stock Jumps. The Wegovy Pill Is Back in Focus Yahoo Finance Novo Nordisk sees pills capturing over third of […]
Novo’s Wegovy pill tracks 3,071 prescriptions in first days of launch – Reuters
Novo’s Wegovy pill tracks 3,071 prescriptions in first days of launch Reuters Novo Nordisk shares rise 8% after Wegovy obesity pill has ‘solid’ launch CNBC Lubbock Doctor compares weight loss injections to new pills KCBD Novo Nordisk Stock Jumps. The Wegovy Pill Is Back in Focus Yahoo Finance Novo Nordisk sees pills capturing over third of GLP-1 obesity market […]
‘Bar Rescue’ host Jon Taffer on new restaurant reality: Smaller portions, lighter appetites and higher costs
America’s restaurant industry is quietly reworking its playbook as weight-loss drugs change how people eat, how much food they leave behind and what they are willing to pay. “Bar Rescue” host Jon Taffer joined FOX Business’ Stuart Varney on “Varney & Co.” to explain how the rise of weight-loss drugs is changing consumer behavior. Taffer […]
Incretin Based Therapy in Heart Failure with Preserved Ejection Fraction
Join the American Heart Association for an insightful session with Dr. Clyde Yancy and Dr. Dhruv Kazi. Recent clinical trials demonstrate the efficacy of incretin-based therapies (including GLP1-RA) in the care of HFpEF patients and their pivotal role in improving patient quality of life. Dr. Clyde Yancy discusses the latest evidence from these landmark trials […]
Arthur Brooks: Do GLP-1s Make Us Happy?
In my column last Monday, I wrote about how to make better New Year’s resolutions—ones that are less likely to flop, but that are also challenging enough to provide satisfaction. Why? Because accomplishing something with a degree of struggle is the way to realize joy. I gave the example of using GLP-1 drugs for weight […]
Wegovy pill off to a fast start; Ex-Emergent CEO sued for insider trading
More than 3,000 prescriptions were written for Novo’s GLP-1 pill in its first week on the market. Elsewhere, Emergent reached a settlement over a trading scandal and Sanofi is reportedly circling an eye drug biotech.
‘Another self own’: Trump comment sparks internet rumors of president on Ozempic
President Donald Trump touted Friday his new health care plan, which he dubbed “The Great Health Care Plan” during a press conference from the White House, but his meandering remarks about a “friend” who took the weight-loss drug Ozempic quickly fueled online speculation about whether the president himself was using it. “A friend of mine […]